Curocell (XKRX:372320) Beginning Cash Position : ₩6,625.75 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Beginning Cash Position?

Curocell's Beginning Cash Position for the quarter that ended in Jun. 2023 was ₩6,625.75 Mil.

Curocell's quarterly Beginning Cash Position declined from Jun. 2022 (₩42,590.23 Mil) to Dec. 2022 (₩4,911.86 Mil) but then increased from Dec. 2022 (₩4,911.86 Mil) to Jun. 2023 (₩6,625.75 Mil).

Curocell's annual Beginning Cash Position increased from Dec. 2021 (₩3,407.22 Mil) to Dec. 2022 (₩42,590.23 Mil) but then declined from Dec. 2022 (₩42,590.23 Mil) to Dec. 2023 (₩6,625.75 Mil).

Curocell Beginning Cash Position Historical Data

The historical data trend for Curocell's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Beginning Cash Position Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

261.45

845.79

3,407.22

42,590.23

6,625.75

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	42,590.23	4,911.86	6,625.75	-

Curocell Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Curocell Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Curocell's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines